ASTRAZENECA PHARMA INDIA
Astrazeneca Pharma India Share Price
Astrazeneca Pharma India Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Astrazeneca Pharma India Investment Rating
-
Master Rating:
-
Astrazeneca Pharma India has an operating revenue of Rs. 862.53 Cr. on a trailing 12-month basis. An annual revenue de-growth of -1% needs improvement, Pre-tax margin of 10% is healthy, ROE of 12% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 6% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 90 which is a GREAT score indicating consistency in earnings, a RS Rating of 61 which is FAIR indicating the recent price performance, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 107 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
- Indicator
- Jun 2022
- Mar 2022
- Dec 2021
- Sep 2021
- Jun 2021
- Mar 2021
- Oper Rev Qtr Cr
- 232
- 232
- 201
- 198
- 175
- 210
- Operating Expenses Qtr Cr
- 204
- 194
- 186
- 180
- 160
- 170
- Operating Profit Qtr Cr
- 28
- 38
- 15
- 18
- 16
- 40
- Depreciation Qtr Cr
- 5
- 4
- 4
- 4
- 5
- 6
- Interest Qtr Cr
- 0
- 0
- 0
- 0
- 0
- 0
- Tax Qtr Cr
- 7
- 9
- 5
- 4
- 3
- 10
- Net Profit Qtr Cr
- 20
- 28
- 11
- 12
- 10
- 27
Astrazeneca Pharma India Technicals
EMA & SMA

- Bullish Moving Average
- ___
- 10
- Bearish Moving Average
- ___
- 6
- 20 Day
- 3058.12
- 50 Day
- 2964.74
- 100 Day
- 2905.61
- 200 Day
- 2874.79
- 20 Day
- 3072.01
- 50 Day
- 2940.55
- 100 Day
- 2825.72
- 200 Day
- 2873.15
Astrazeneca Pharma India Resistance and Support
- First Resistance
- 3112.94
- Second Resistance
- 3156.12
- Third Resistance
- 3189.09
- First Resistance
- 3036.79
- Second Resistance
- 3003.82
- Third Resistance
- 2960.64
- RSI
- 53.14
- MFI
- 65.17
- MACD Single Line
- 55.85
- MACD
- 46.34
Astrazeneca Pharma India Delivery and Volume
- Period
- NSE + BSE
Volume Avg - NSE + BSE
Delivery Volume Avg - NSE + BSE
Delivery Volume %
- Day
- 6,294
- 435,230
- 69.15
- Week
- 7,491
- 398,808
- 53.24
- 1 Month
- 12,984
- 681,668
- 52.5
- 6 Month
- 15,926
- 702,658
- 44.12
Astrazeneca Pharma India Result Highlights
AstraZeneca Pharma India Synopsis
NSE-Medical-Diversified
Astrazeneca Pharma I is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 805.60 Cr. and Equity Capital is Rs. 5.00 Cr. for the Year ended 31/03/2022. AstraZeneca Pharma India Ltd. is a Public Limited Listed company incorporated on 11/07/1979 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L24231KA1979PLC003563 and registration number is 003563.- Market Cap
- 7,657
- Sales
- 863
- Shares in Float
- 0.63
- No of funds
- 80
- Yield
- 0.33
- Book Value
- 14.93
- U/D Vol ratio
- 2
- LTDebt / Equity
- Alpha
- -0.02
- Beta
- 0.46
AstraZeneca Pharma India
- Owner Name
- Jun-22
- Mar-22
- Dec-21
- Sep-21
- Promoters
- 75%
- 75%
- 75%
- Mutual Funds
- 1.07%
- 0.99%
- 0.97%
- Insurance Companies
- 0.03%
- 0.03%
- 0.03%
- Foreign Portfolio Investors
- 2.48%
- 2.38%
- 2.38%
- Financial Institutions/ Banks
- Individual Investors
- 18.63%
- 19.06%
- 19.44%
- Others
- 2.79%
- 2.54%
- 2.18%
AstraZeneca Pharma India Management
- Name
- Designation
- Mr. Narayan K Seshadri
- Chairman & Ind.Director
- Mr. Gagandeep Singh Bedi
- Executive Director
- Mr. Rajesh Marwaha
- Executive Director
- Mr. Ankush Nandra
- Non Executive Director
- Ms. Weiying Sarah Wang
- Non Executive Director
- Ms. Revathy Ashok
- Independent Director
- Ms. Shilpa Shidhar Divekar
- Independent Director
Astrazeneca Pharma India Forecast
Price Estimates
Astrazeneca Pharma India Corporate Action
- Date
- Purpose
- Remarks
- 2022-08-08
- Quarterly Results
- 2022-05-26
- Audited Results & Final Dividend
- 2022-02-08
- Quarterly Results
- 2021-11-09
- Quarterly Results
- 2021-08-09
- Quarterly Results & Interim Dividend
- Date
- Purpose
- Remarks
- 2022-07-08
- FINAL
- Rs.8.00 per share(400%)Final Dividend
- 2021-08-20
- INTERIM
- Rs.2.00 per share(100%)Interim Dividend
AstraZeneca Pharma India FAQs
What is Share Price of AstraZeneca Pharma India ?
AstraZeneca Pharma India share price is ₹3055 As on 16 August, 2022 | 22:37
What is the Market Cap of AstraZeneca Pharma India ?
The Market Cap of AstraZeneca Pharma India is ₹7637.6 Cr As on 16 August, 2022 | 22:37
What is the P/E ratio of AstraZeneca Pharma India ?
The P/E ratio of AstraZeneca Pharma India is 106.8 As on 16 August, 2022 | 22:37
What is the PB ratio of AstraZeneca Pharma India ?
The PB ratio of AstraZeneca Pharma India is 14.9 As on 16 August, 2022 | 22:37